{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:20:10Z","timestamp":1788304810179,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"South African National Research Foundation (NRF)"},{"name":"South African Medical Research Council (SAMRC) Unit on Immunology of Infectious Diseases (FB)"},{"DOI":"10.13039\/100007675","name":"International Center for Genetic Engineering and Biotechnology (ICGEB)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007675","id-type":"DOI","asserted-by":"crossref"}]},{"name":"South African Research Chair initiative (SARChi)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.imlet.2013.12.022","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:01:18Z","timestamp":1389139278000},"page":"179-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["The role of IL-4 and IL-13 in cutaneous Leishmaniasis"],"prefix":"10.1016","volume":"161","author":[{"given":"Ramona","family":"Hurdayal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Brombacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.imlet.2013.12.022_bib0005","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.184.3.1127","article-title":"IL-4-deficient Balb\/c mice resist infection with Leishmania major","volume":"184","author":"Kopf","year":"1996","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.imlet.2013.12.022_bib0010","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.4049\/jimmunol.164.3.1458","article-title":"IL-13 is a susceptibility factor for Leishmania major infection","volume":"164","author":"Matthews","year":"2000","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.imlet.2013.12.022_bib0015","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.4049\/jimmunol.162.12.7302","article-title":"Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling","volume":"162","author":"Mohrs","year":"1999","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.imlet.2013.12.022_bib0020","doi-asserted-by":"crossref","first-page":"pe68","DOI":"10.1371\/journal.ppat.0030068","article-title":"Deletion of IL-4Ralpha on CD4 T cells renders BALB\/c mice resistant to Leishmania major infection","volume":"3","author":"Radwanska","year":"2007","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1016\/j.imlet.2013.12.022_bib0025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ni725","article-title":"IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB\/c mice","volume":"2","author":"Biedermann","year":"2001","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.imlet.2013.12.022_bib0030","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.4049\/jimmunol.162.10.6132","article-title":"IL-4- and IL-4 receptor-deficient BALB\/c mice reveal differences in susceptibility to Leishmania major parasite substrains","volume":"162","author":"Noben-Trauth","year":"1999","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.imlet.2013.12.022_bib0035","doi-asserted-by":"crossref","first-page":"e1003699","DOI":"10.1371\/journal.ppat.1003699","article-title":"Deletion of IL-4 Receptor Alpha on Dendritic Cells Renders BALB\/c Mice Hypersusceptible to Leishmania major Infection","volume":"9","author":"Hurdayal","year":"2013","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.imlet.2013.12.022_bib0040","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/1521-4141(200010)30:10<2935::AID-IMMU2935>3.0.CO;2-Q","article-title":"Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis","volume":"30","author":"Alexander","year":"2000","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.imlet.2013.12.022_bib0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/infdis\/jir080","article-title":"Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Ralpha-responsive macrophages and neutrophils","volume":"204","author":"McFarlane","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.imlet.2013.12.022_bib0050","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1128\/IAI.74.4.2487-2490.2006","article-title":"Visceral Leishmania donovani infection in interleukin-13\u2212\/\u2212 mice","volume":"74","author":"Murray","year":"2006","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.imlet.2013.12.022_bib0055","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.4049\/jimmunol.161.11.6180","article-title":"Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis","volume":"161","author":"Stamm","year":"1998","journal-title":"J Immunol"},{"issue":"5251","key":"10.1016\/j.imlet.2013.12.022_bib0060","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.271.5251.987","article-title":"Susceptibility to Leishmania major infection in interleukin-4-deficient mice","volume":"271","author":"Noben-Trauth","year":"1996","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.imlet.2013.12.022_bib0065","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/iai.63.12.4894-4899.1995","article-title":"Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection","volume":"63","author":"Satoskar","year":"1995","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.imlet.2013.12.022_bib0070","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/1521-4141(2002010)32:10<2923::AID-IMMU2923>3.0.CO;2-E","article-title":"An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection","volume":"32","author":"Alexander","year":"2002","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.imlet.2013.12.022_bib0075","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4049\/jimmunol.176.2.1115","article-title":"Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB\/c mice","volume":"176","author":"Holscher","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.imlet.2013.12.022_bib0080","doi-asserted-by":"crossref","first-page":"e930","DOI":"10.1371\/journal.pntd.0000930","article-title":"BALB\/c mice deficient in CD4 T cell IL-4Ralpha expression control Leishmania mexicana Load although female but not male mice develop a healer phenotype","volume":"5","author":"Bryson","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.imlet.2013.12.022_bib0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1074-7613(00)80625-1","article-title":"Impaired development of Th2 cells in IL-13-deficient mice","volume":"9","author":"McKenzie","year":"1998","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.imlet.2013.12.022_bib0090","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.4049\/jimmunol.159.10.5005","article-title":"SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis","volume":"159","author":"Satoskar","year":"1997","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.imlet.2013.12.022_bib0095","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/IAI.68.4.1773-1780.2000","article-title":"Interleukin-4 receptor alpha-deficient BALB\/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection","volume":"68","author":"Mohrs","year":"2000","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.imlet.2013.12.022_bib0100","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3621::AID-IMMU3621>3.0.CO;2-Z","article-title":"Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection","volume":"29","author":"Kropf","year":"1999","journal-title":"Eur J Immunol"},{"issue":"20","key":"10.1016\/j.imlet.2013.12.022_bib0105","doi-asserted-by":"crossref","first-page":"10838","DOI":"10.1073\/pnas.94.20.10838","article-title":"An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice","volume":"94","author":"Noben-Trauth","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.imlet.2013.12.022_bib0110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fimmu.2012.00080","article-title":"T helper1\/t helper2 cells and resistance\/susceptibility to leishmania infection: is this paradigm still relevant?","volume":"3","author":"Alexander","year":"2012","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.imlet.2013.12.022_bib0115","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.168.5.1675","article-title":"Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens","volume":"168","author":"Scott","year":"1988","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.imlet.2013.12.022_bib0120","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/IAI.68.7.4075-4083.2000","article-title":"Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice","volume":"68","author":"Holscher","year":"2000","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.imlet.2013.12.022_bib0125","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1074-7613(04)00107-4","article-title":"Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology","volume":"20","author":"Herbert","year":"2004","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.imlet.2013.12.022_bib0130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.192.6.823","article-title":"Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells","volume":"192","author":"Hochrein","year":"2000","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.imlet.2013.12.022_bib0135","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.4049\/jimmunol.169.7.3574","article-title":"Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF","volume":"169","author":"Lutz","year":"2002","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.imlet.2013.12.022_bib0140","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1084\/jem.20050324","article-title":"Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells","volume":"201","author":"Yao","year":"2005","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.imlet.2013.12.022_bib0145","doi-asserted-by":"crossref","first-page":"e1721","DOI":"10.1371\/journal.pntd.0001721","article-title":"Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after leishmania major infection of BALB\/c mice","volume":"6","author":"Masic","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"9\u201310","key":"10.1016\/j.imlet.2013.12.022_bib0150","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.vaccine.2003.09.030","article-title":"A mixed Th1\/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB\/c mice","volume":"22","author":"Mazumdar","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.imlet.2013.12.022_bib0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/IAI.69.1.245-251.2001","article-title":"Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection","volume":"69","author":"Gicheru","year":"2001","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.imlet.2013.12.022_bib0160","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.163.8.4481","article-title":"Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis","volume":"163","author":"Kenney","year":"1999","journal-title":"J Immunol"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247814000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247814000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:33:40Z","timestamp":1759044820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247814000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0165247814000042"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2013.12.022","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of IL-4 and IL-13 in cutaneous Leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2013.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}